✦ LIBER ✦

Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports)

✍ Scribed by Franco Kokelj; Carmela Plozzer; Pierpaolo Torsello; Giusto Trevisan

Book ID: 118604857
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 26 KB
Volume: 11
Category: Article
ISSN: 0926-9959
DOI: 10.1016/s0926-9959(98)00060-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of cyclosporine plus etretinate

Efficacy of cyclosporine plus etretinate in the treatment of erythrodermie psoriasis (three case reports)

✍ Franco Kokelj; Carmela Plozzer; Pierpaolo Torsello; Giusto Trevisan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Combination of etretinate with cyclospor

Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis

✍ Brechtel, Bärbel; Wellenreuther, Uta; Toppe, Esdert; Czarnetzki, Beate M. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 385 KB

The efficacy of low-dose cyclosporine a

The efficacy of low-dose cyclosporine a therapy in psoriasis in comparison to etretinate

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 73 KB

International studies of the efficacy of

International studies of the efficacy of etretinate in the treatment of psoriasis

✍ Ehmann, Carl W.; Voorhees, John J. 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 418 KB

Clinical experience of ustekinumab in th

Clinical experience of ustekinumab in the treatment of erythrodermic psoriasis: A case series

✍ Ting-Shun WANG; Tsen-Fang TSAI 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 228 KB

Etretinate or cyclosporin-A treatment no

Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis

✍ R. E. Schopf; J. Höcher; M. Rehder; L. FÄrber; B. Morsches 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 558 KB

During a therapeutic trial to treat psoriasis with either etretinate or cyclosporin A (CyA) we measured the respiratory burst activity of polymorphonuclear leukocytes (PMN). Six patients received 0.5-0.75 mg/kg etretinate and 14 patients 2.5-5.0 mg/kg CyA over a period of 10 weeks. The extent of pso